Chembio Diagnostics, Inc. (CEMI.OB) Announces FDA Approval for Extended Age Range for Routine HIV Testing
Chembio Diagnostics, Inc. (CEMI.OB), a developer, manufacturer and marketer of proprietary rapid diagnostic tests in the growing $5 billion point-of-care…